Chen; Shu-Ping

Patent Applications and Registrations

Patent applications and USPTO patent grants for Chen; Shu-Ping.The latest application filed is for "crystalline and non-crystalline forms of sglt2 inhibitors".

Company Profile

0.11.22

Chen; Shu-Ping - Kaohsiung TW
Chen; Shu-Ping - New Taipei N/A TW
Chen; Shu-Ping - Kaohsiung City TW
CHEN; SHU-PING - Tu-Cheng TW
Chen; Shu-Ping - Kaohsiung City 807 TW
Chen, Shu-Ping - Taipei TW

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Crystalline and non-crystalline forms of SGLT2 inhibitors Grant 8,999,941 - Henschke , et al. April 7, 2	2015-04-07
Electronic device and method for unlocking electronic device Grant 8,826,416 - Chen , et al. September 2, 2	2014-09-02
Crystalline And Non-crystalline Forms Of Sglt2 Inhibitors App 20130237487 - Henschke; Julian Paul ; et al.	2013-09-12
Electronic Device And Method For Setting Editing Tools Of The Electronic Device App 20130222278 - CHEN; SHU-PING ; et al.	2013-08-29
Electronic Device And Method For Unlocking Electronic Device App 20130219488 - CHEN; SHU-PING ; et al.	2013-08-22
Electronic Device, Storage Medium, And Method For Detecting Compatibility Of Files Of The Electronic Device App 20130124485 - CHIU; HSIAO-PING ; et al.	2013-05-16
Electronic Device And Agenda Management Method App 20130080889 - CHEN; SHU-PING ; et al.	2013-03-28
Crystalline forms of docetaxel and process for preparation thereof Grant 8,357,811 - Liao , et al. January 22, 2	2013-01-22
Electronic Device, Storage Medium And Method For Managing Files In The Electronic Device App 20130010000 - CHIU; HSIAO-PING ; et al.	2013-01-10
Crystalline polymorphs of gemcitabine base Grant 8,350,023 - Chen , et al. January 8, 2	2013-01-08
Polymorphic form of granisetron hydrochloride and methods of making the same Grant 8,193,217 - Chen , et al. June 5, 2	2012-06-05
Crystalline polymorph of 7-ethyl-10-hydroxycamptothecin Grant 8,138,343 - Chen , et al. March 20, 2	2012-03-20
Crystalline forms of topotecan hydrochloride and processes for making the same Grant 8,013,158 - Hu , et al. September 6, 2	2011-09-06
Polymorphic Form Of Granisetron Hydrochloride And Methods Of Making The Same App 20100048613 - Chen; Shu-Ping ; et al.	2010-02-25
Crystalline forms of docetaxel and process for preparation thereof Grant 7,662,980 - Liao , et al. February 16, 2	2010-02-16
Crystalline Polymorphs of Gemcitabine Base App 20090326214 - Chen; Shu-Ping ; et al.	2009-12-31
Crystalline Forms of Docetaxel and process for Preparation Thereof App 20090275762 - Liao; Yuan-Xiu ; et al.	2009-11-05
Method of crystallizing carvedilol phosphate and the product thereof App 20090076283 - Shih; Wen-Li ; et al.	2009-03-19
Levonorgestrel Crystallization App 20090069584 - Chang; Yu-Sheng ; et al.	2009-03-12
Crystalline polymorph of exemestane App 20090018356 - Chen; WeiYu ; et al.	2009-01-15
Crystalline polymorph of 7-ethyl-10-hydroxycamptothecin App 20090012111 - Chen; Shu-Ping ; et al.	2009-01-08
Process for preparing aromatase inhibitors App 20080275259 - Chen; WeiYu ; et al.	2008-11-06
Crystalline forms of topotecan hydrochloride and processes for making the same App 20080269493 - Hu; Tsung-Cheng ; et al.	2008-10-30
Crystal forms of irinotecan hydrochloride Grant 7,435,818 - Chen , et al. October 14, 2	2008-10-14
Crystalline forms of docetaxel and process for preparation thereof App 20080108693 - Liao; Yuan-Xiu ; et al.	2008-05-08
Novel crystal forms of irinotecan hydrochloride App 20070072890 - Chen; Shu-Ping ; et al.	2007-03-29
Laser ablation technique using in IC etching process App 20030136769 - Lin, Yue-Yeh ; et al.	2003-07-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.